Integre Asset Management’s Integra LifeSciences IART Stock Holding History

Integre Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,180	Closed	-$431K	–	124
2019 Q3	$431K	Hold	7,180	–	–	0.26%	62
2019 Q2	$401K	Hold	7,180	–	–	0.23%	69
2019 Q1	$400K	Buy	7,180 +114	+2%	+$5.81K	0.24%	67
2018 Q4	$319K	Buy	+7,066	New	+$388K	0.23%	65
2018 Q1	–	Sell	-2,894	Closed	-$139K	–	123
2017 Q4	$139K	Buy	+2,894	New	+$142K	0.08%	132
2014 Q3	–	Sell	-307,984	Closed	-$5.92M	–	155
2014 Q2	$5.92M	Sell	307,984 -854	-0.3%	-$15.9K	1.26%	30
2014 Q1	$5.81M	Buy	308,838 +17,879	+6%	+$345K	1.27%	29
2013 Q4	$5.67M	Sell	290,959 -594	-0.2%	-$10.9K	1.29%	32
2013 Q3	$4.8M	Sell	291,553 -33,453	-10%	-$537K	1.24%	31
2013 Q2	$4.87M	Buy	+325,006	New	+$4.76M	1.31%	27

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Integre Asset Management's IART Position: Q4 2019 in Review

Integre Asset Management sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 7,180 shares — an estimated $431K sold.

Integre Asset Management first reported a position in IART in Q2 2013 and held it in 10 quarters. The position peaked at $5.92M in Q2 2014. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

Integre Asset Management reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
Integre Asset Management sold 7,180 Integra LifeSciences shares in Q4 2019, an estimated $431K.
Integre Asset Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 10 quarters.
Integre Asset Management's Integra LifeSciences position peaked at $5.92M in Q2 2014.
279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Integre Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.